What Is Barbiturates? Drug Class, Schedule & Drug Test Answers
Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated September 2026
Quick answer: Barbiturates is a Depressant (GABA-A prolonger). Schedule II–IV by agent. Here's how the drug is classified, whether it's a narcotic/controlled substance, and what that means for testing.
What is Barbiturates?
Drug class: Depressant (GABA-A prolonger)
Federal schedule: Schedule II–IV by agent.
Barbiturates ride along on 10/12-panel cups as the legacy 'BAR' strip. Prescriptions are uncommon today (butalbital migraine combos like butalbital migraine tablets persist).
Is Barbiturates a narcotic?
It is classified as a narcotic under the DEA's federal schedule. What matters more for you: Schedule II–IV by agent..
Does it show up on drug tests?
No — it is not on the standard 5-panel; it appears only on expanded or panel-specific orders. See the full Barbs drug test guide for detection windows and cutoffs.
Certified labs nationwide · Results in 1–2 days
Need a test? Order online, test same-day →People also ask
Do Barbiturates Show up on a Drug Test?
No — Barbs is absent from standard drug panels. Full guide →
How Long Do Barbiturates Stay in Your Urine?
How long Barbs stays detectable in urine — urine, hair, saliva & blood windows explained with cutoffs. Full guide →
How to Pass a Drug Test for Barbiturates?
Evidence-based ways to pass a drug test for Barbs — realistic timelines, what works, what backfires, and dilution flags to avoid. Full guide →
Barbiturates Drug Test Guide: Panels, Detection Windows & More?
Complete Barbs drug test guide: which panels detect it, urine/hair/saliva/blood detection windows, cutoff levels and prescription verification. Full guide →
Do prescriptions count against me?
No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.
Sources & further reading
- SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
- DOT — 49 CFR Part 40 procedures for transportation workplace testing
- Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
- FDA — drug-of-abuse test device labeling (detection window conventions)